Infertility Clinical Trial
Official title:
Molecular Markers of Human Sperm Function
Objectives:
Male factor infertility is poorly understood and our ability to evaluate the male
contribution to a couple's infertility is very limited. The overarching goal of this project
is to understand at the molecular level what functional activities in human sperm are
required for successful fertilization leading to full term development. These findings will
allow us to develop new methods to determine the impact of environmental exposures on sperm
quality and male fertility.
A sperm protein known as phospholipase C zeta (PLC zeta) initiates embryo development at
fertilization. The primary objective of this study is to test the hypothesis that human PLC
zeta activity correlates directly with the proportion of fertilized eggs that undergo early
cleavage during an in vitro fertilization (IVF) cycle. Secondary objectives for the study
are to generate preliminary data regarding the variability in sperm PLC zeta activity within
and between individuals and to determine if there are clinical or laboratory correlates for
sperm PLC zeta activity.
Study population:
The study population will consist of 178 infertile couples undergoing IVF procedures at Duke
Fertility Center (DFC) from which we will obtain 154 evaluable couples for the study.
Overall Design:
An observational cohort study design will be used to assess the association of PLC zeta
activity in the residual sperm from the sample used for an IVF cycle with the proportion of
eggs per couple that undergo early cleavage during the same cycle. Infertile couples
enrolling in an IVF treatment cycle at DFC will be approached for inclusion in the study.
Consent will be obtained from both male and female partners, and historical medical
information and information about their IVF cycle will be collected by chart review. Blood
for isolation of serum and DNA will be collected only from the male partner for evaluation
of hormone levels and genetic analyses related to infertility. On the day of the egg
retrieval, residual sperm not needed for clinical purposes will be transported via courier
to NIEHS. Sperm PLC zeta activity will be measured in the investigator's laboratory using an
experimental bioassay. Sperm PLC zeta protein will be analyzed at the University of
Massachusetts.
Outcome Parameters:
The primary outcome will be the proportion of embryos that undergo early cleavage. Secondary
outcomes will include proportion of eggs fertilized, embryo development parameters, and p...
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 2009 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 19 Years and older |
Eligibility |
- INCLUSION CRITERIA: - Infertile couples undergoing an ART cycle at DFC in which eggs are retrieved from the female partner. This type of ART cycle comprises approximately 80-90 percent of the ART cycles at DFC. - Infertile couples undergoing an ART cycle at DFC in which the eggs are retrieved from an anonymous egg donor. Approximately 10-20 percent of the ART cycles at DFC involve anonymous egg donation. - Willing and able to provide informed consent. - Age greater than or equal to 18 (both partners in couple). Essentially all infertile couples who enter clinical ART programs at least age 18. EXCLUSION CRITERIA: - Previous completed participation in the study. A complete data set will be obtained from either partner of a couple only once for this study. - Cancellation of the ART cycle prior to egg retrieval, or no fertilizable eggs retrieved. In this case it would not be possible to determine our primary outcome. - Age less than 18 (either partner in couple). Because they so rarely experience clinical infertility, we do not expect any couples under age 18 to enter the ART program, so we will not include these as subjects. - Use of frozen sperm to inseminate eggs. The rationale for this exclusion is that the effect of cryopreservation reagents on PLC zeta activity is unknown, and very few of the ART cycles at DFC utilize donor sperm so we would not be able to control appropriately for this confounder. |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Duke University | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
National Institute of Environmental Health Sciences (NIEHS) |
United States,
Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23. 2005 Dec;(25):1-160. — View Citation
Esfandiari N, Javed MH, Gotlieb L, Casper RF. Complete failed fertilization after intracytoplasmic sperm injection--analysis of 10 years' data. Int J Fertil Womens Med. 2005 Jul-Aug;50(4):187-92. — View Citation
Kouchi Z, Fukami K, Shikano T, Oda S, Nakamura Y, Takenawa T, Miyazaki S. Recombinant phospholipase Czeta has high Ca2+ sensitivity and induces Ca2+ oscillations in mouse eggs. J Biol Chem. 2004 Mar 12;279(11):10408-12. Epub 2003 Dec 29. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A |